Drug Combo Effective in Cancer Models, University of London Study

MedPage Today -- WASHINGTON -- A thalidomide analogue called lenalidomide (Revlimid), combined with the taxane docetaxel (Taxotere), may improve survival in cell and animal models of hormone-resistant metastatic prostate cancer, a British researcher reported here.